BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
search help

Documents 1-13 out of 13 found
  Current Search:  gabitril: 133, tiagabine: 87, hydrochloride: 3359  

100%
TEXT
http://www.fda.gov/cder/orange/appendix_a.txt
RTU IN PLASTIC CONTAINER, METRONIDAZOLE FLAGYL I.V., METRONIDAZOLE HYDROCHLORIDE FLAGYL, METRONIDAZOLE FLAREX, FLUOROMETHOLONE ACETATE FLAVORED COLESTID, COLESTIPOL HYDROCHLORIDE FLAVOXATE HCL, FLAVOXATE HYDROCHLORIDE FLAXEDIL, GALLAMINE TRIETHIODIDE FLECAINIDE ACETATE, FLECAINIDE ACETATE FLEXERIL, CYCLOBENZAPRINE HYDROCHLORIDE FLEXICORT, HYDROCORTISONE FLOLAN...

Matching: gabitril tiagabine hydrochloride Find similar documents More document info
100%
HTML
Prescription and OTC Drug Product List 6/2002
-D- + WYETH AYERST 20,000 UNITS/VIAL N17055 003 JUN DISC -A- @ 20,000 UNITS/VIAL N17055 003 JUN DISC CHORIONIC GONADOTROPIN -D- + STERIS 2,000 UNITS/VIAL N17016 011 FEB 16, 1990 JUN DISC -A- @ 2,000 UNITS/VIAL N17016 011 FEB 16, 1990 JUN DISC GRANISETRON HYDROCHLORID E SOLUTION; ORAL KYTRIL -D- + ROCHE EQ 2MG BASE/10ML N21238 001 JUN 27, 2001 JUN DISC -A- @ EQ 2MG BASE/10ML N21238...
Matching: gabitril tiagabine hydrochloride Find similar documents More document info
100%
PDF
http://www.phrma.org/newmedicines/resources/2002-12-20.99.pdf page 2


Matching: gabitril tiagabine hydrochloride Find similar documents More document info

100%
HTML
Prescription and OTC Drug Product List 12/2000
Prescription and Over-the-Counter Drug Product List - 20th Edition Cumulative Supplement Number 12: December 2000 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE - ADD - BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE TABLET; ORAL - ADD - GEL; TOPICAL OXYCODONE AND ACETAMINOPHEN - ADD - BENZACLIN - ADD - AA WATSON...
Matching: gabitril tiagabine hydrochloride Find similar documents More document info
100%
HTML
FDA Drug Approvals List- April 1999
Original Application #: 050760 Approval Date: 15-APR-99 Trade Name: AMOXIL Chemical Type: 3 Therapeutic Potential: S Dosage Form: SUSPENSION Applicant: SMITHKLINE BEECHAM PHARMACEUTICALS Active Ingredient(s): AMOXICILLIN OTC/RX Status: RX Indication(s):For the use of Amoxil for oral suspension 200mg/5mL and 400mg/5mL in divided doses q12h Original Application #: 020924 Approval Date:...
Matching: gabitril tiagabine hydrochloride Find similar documents More document info
100%
HTML
Drug Approvals October 1996
Drug Approvals for October 1996 Definitions and Notes October 1996 Original New Drug Applications Original Application #: 019821 Approval Date: 28-OCT-96 Trade Name: SORIATANE Chemical Type: 2 Therapeutic Potential: S Dosage Form: CAPSULE Applicant: HOFFMAN-LAROCHE Active Ingredient(s): ACITRETIN OTC/RX Status: RX Indication(s): Treatment of severe psoriasis Original Application #:...
Matching: gabitril tiagabine hydrochloride Find similar documents More document info
100%
HTML
Drug Approvals for September 1997
Drug Approvals for September 1997 Definitions and Notes September 1997 Original New Drug Applications Original Application #: 020758 Approval Date: 30-SEP-97 Trade Name: IRBESARTAN - HYDROCHLOROTHIAZIDE Chemical Type: 1,4 Therapeutic Potential: S Dosage Form: TABLET Applicant: SANOFI PHARMACEUTICALS INC Active Ingredient(s): HYDROCHLOROTHIAZIDE; IRBESARTAN OTC/RX Status: RX...
Matching: gabitril tiagabine hydrochloride Find similar documents More document info
75%
HTML
Tiagabine for epilepsy - [Medication] - Quest Diagnostics Patient Health Library
Tiagabine for epilepsy Examples Brand Name Chemical Name Gabitril tiagabine Tiagabine requires several oral doses each day.
Why It Is Used Tiagabine is used in combination with other antiepileptic medications in adults and children over age 12 to control partial seizures.
Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works -...
Matching: gabitril tiagabine Find similar documents More document info
75%
HTML
Cephalon Inc.
Clinical Data The following list cites selected publications and is not intended to be a complete list of published research in therapeutic areas of interest to Cephalon.
1998;16:3238-3245.
1998;90:611-616.
Portenoy RK, Payne R, Coluzzi P, et al.
PROVIGIL Czeisler CA, Walsh JK, et al.- Modafinil for excessive sleepiness associated with shift-work sleep disorder.
Matching: gabitril tiagabine Find similar documents More document info
75%
HTML
Prescription Drug Information
(You will be leaving the UMHS site to enter the MEDLINEplus site.) To browse by first letter of generic or brand name drug: A - Am An - Az B C - Ch Ci - Cz D - Dh Di - Dz E F G H I - J K - L M - Mh Mi - Mz N - Nh Ni - Nz O P - Pl Pm - Pz Q - R S - Sn So - Sz T - To Tp - Tz U - V W - Z 0 - 9 - UMHS provides additional drug information on these topics: Anticoagulant - Coumadin/Warfarin...
Matching: gabitril tiagabine Find similar documents More document info
75%
HTML
BioPortfolio Limited
Treatment of Epilepsy 5.1 Monotherapy is the Preferable Treatment for Epilepsy 5.2 Monotherapies Do Not Dominate the Anticonvulsant Market 5.3 Brand Name Medications are Important for Epilepsy Sufferers 5.4 Anticonvulsants Can Be Divided into Two Groups: First- and Second-Generation 5.5 First-Generation Anticonvulsants 5.5.1 Carbamazepine (Tegretol/Carbatrol) 5.5.2 Valproate ...
Matching: gabitril tiagabine Find similar documents More document info
75%
HTML
rld_labeling_approved_apr_1999
Firm Date VEPESID Etoposide Capsule Etoposide Injection 19-557 18-768 S-023 S-041 Bristol 2-Apr-1999 NOLVADEX Tamoxifen Citrate Tablet 17-970 S-043 Zeneca Pharms 2-Apr-1999 ZOLADEX 3-MONTH Goserelin Acetate Implant 20-578 S-001 Zeneca Pharms 14-Apr-1999 CHILDREN'S MOTRIN ORAL SUSPENSION 40 MG/ML Ibuprofen Oral Suspension (Concentrated - Drops) 20-603 S-003 Mc Neil 15-Apr-1999 ...
Matching: gabitril tiagabine Find similar documents More document info
63%
PDF
Report.PDF page 10


author: default
Matching: tiagabine hydrochloride Find similar documents More document info


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.